Brian I. Carr, MD, FRCP, PhD
Director

2014

The idea behind this book stems from the apparent complexity of hepatocellular carcinoma (HCC), as its management and prognosis are influenced by two separate yet interacting diseases, namely the underlying liver disease, which is often inflammatory, and the HCC. All textbooks mention this and systematically explore the causes, modifying factors, radiological tests and the many treatment options of both sets of diseases. The aim of this new text is to synthesize these various influences, especially with regard to therapy choices.